Expression of BCL-2 gene product in embryonal tumors of the central nervous system

Surgical Neurology

Volumn 45, Issue 3, 1996, Pages 230-234

  Oka, Hidehiro ^a,b   Satoh, Yuichi ^a   Kawano, Nobuyuki ^a   Yagishita, Saburo ^b   Kameya, Toru ^a  

^a KANAGAWA REHABILITATION CENTER   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; bcl 2; Central nervous system; Embryonal tumor; Neuronal differentiation

Indexed keywords

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; EMBRYONAL CARCINOMA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; INFANT; MALE; NERVE CELL DIFFERENTIATION;

ADOLESCENT; ADULT; APOPTOSIS; CELL DIFFERENTIATION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION; GTP-BINDING PROTEINS; HUMANS; INFANT; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0029996122     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/0090-3019(95)00367-3     Document Type: Article

References (25)

1. Allsopp TE, Wyatt S, Paterson HF, Davies AM. The protooncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 1993;73:295-307.
2. Bakhshi A, Jensen JP, Goldman P, Wright JJ, McBride OW, Epstein AL, Korsmeyer SJ. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on chromosome 18. Cell 1985;41: 899-906.
3. Campos BL, Rouault JP, Sabido O, Oriol P, Roubi N, Vasselon C, Archimbaud E, Magaud JP, Guyotat D. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with response to chemotherapy. Blood 1993;81:3091-6.
4. Castle YP, Heidelberger KP, Bromberg J, Ou X, Mukund D, Nunez G. Expression of the apotosis-suppressing protein bcl-2 in neuroblastoma is associated with unfavorable histology and N-myc amplification. Am J Pathol 1993;143:1543-50.
5. Cleary ML, Sklar J. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 1985;82:7439-43.
6. Colombel M, Symmans F, Gil S, O'Toole KM, Chopin D, Benson M, Olsson CA, Korsmeyer S, Buttyan R. Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers. Am J Pathol 1993;143:390-400.
7. Doglioni C, Tos APD, Laurino L, Chiarelli C, Brabareschi M, Viale G. The prevalence of bcl-2 immunoreactivity in breast carcinomas and its clinicopathological correlates with particular reference to oestrogen receptor status. Virchows Arch 1994;424:47-51.
8. Garcia I, Martinou I, Tsujimoto Y, Martinou J-C. Prevention of programmed cell death of sympathetic neurons by the bcl-2 protooncogene. Science 1992; 258:302-4.
9. Hart MN, Earle KM. Primitive neuroectodermal tumors of the brain in children. Cancer 1973;32:890-7.
10. Hockenberry D, Nunez G, Milliman C, Schreiber R, Korsmeyer S. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990;348:334-6.
11. Hockenberry DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ. Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991;88:6961-5.
12. LeBrun DP, Warnke RA, Cleary ML. Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol 1993;142:743-53.
13. Lu Q, Poulsom R, Wong L, Hanby AM. Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J Pathol 1993;169:432-7.
14. McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LW, Hsieh JT, Tu SM, Campbell ML. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 1992;52:6940-4.
15. Negrini M, Silini E, Kozak C, Tsujimoto Y, Croce CM. Molecular analysis of bcl-2: structure and expression of the murine gene homologous to the human gene involved in follicular lymphoma. Cell 1987;49:455-63.
16. Pezzella F, Tse AGD, Cordell JL, Pulford KAF, Gatter KC, Mason DY. Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol 1990;137:225-32.
17. Ramani P, Lu Q. Expression of bcl-2 gene product in neuroblastoma. J Pathol 1994;172:273-8.
18. Reed JC, Meister L, Tanaka S, Cuddy M, Yum S, Geyer C, Pleasure D. Differential expression of bcl-2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin. Cancer Res 1991;51:6529-38.
19. Rorke LB. The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors. J Neuropathol Exp Neurol 1983;42:1-15.
20. Russell DL, Kaklamanis L, Pezella F, Gatter KC, Adrian L. Bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumors and in situ cancer. Br J Cancer 1994;69:135-9.
21. Saunders J. Death in embryonic systems. Science 1966;154:604-12.
22. Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991;39:741-8.
23. Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 1984;226:1097-9.
24. Williams GT. Programmed cell death: apoptosis and oncogenesis. Cell 1991;65:1097-8.
25. Wyllie A. Apoptosis: cell death in tissue regulation. J Pathol 1987;153:313-6.